Skip to main content
SpringerLink
Log in

The Patient with Liver Disease Undergoing Non-hepatic Surgery

  • Chapter
  • First Online:
Liver Anesthesiology and Critical Care Medicine

  • 1280 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stoelting RK, Stephen F, editors. Anesthesia and co-existing disease. 4th ed. Philadelphia: Churchill Livingstone, Elsevier Inc.; 2002.

    Google Scholar 

  2. del Olmo JA, Flor-Lorente B, Flor-Civera B, Rodriguez F, Serra MA, Escudero A, et al. Risk factors for nonhepatic surgery in patients with cirrhosis. World J Surg. 2003;27(6):647–52.

    Article  PubMed  Google Scholar 

  3. Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90(1):42–53.

    Article  CAS  PubMed  Google Scholar 

  4. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132(4):1261–9.

    Article  PubMed  Google Scholar 

  5. Friedman LS. The risk of surgery in patients with liver disease. Hepatology. 1999;29(6):1617–23.

    Article  CAS  PubMed  Google Scholar 

  6. Rice HE, O’Keefe GE, Helton WS, Johansen K. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg. 1997;132(8):880–4. discussion 4–5

    Article  CAS  PubMed  Google Scholar 

  7. Csikesz NG, Nguyen LN, Tseng JF, Shah SA. Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg. 2009;208(1):96–103.

    Article  PubMed  Google Scholar 

  8. Delis S, Bakoyiannis A, Madariaga J, Bramis J, Tassopoulos N, Dervenis C. Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child-Pugh classification in predicting outcome. Surg Endosc. 2010;24(2):407–12.

    Article  PubMed  Google Scholar 

  9. Miller RD, editor. Miller’s anesthesia. 7th ed. Philadelphia: Churchill Livingstone, Elsevier Inc.; 2010.

    Google Scholar 

  10. Douard R, Lentschener C, Ozier Y, Dousset B. Operative risks of digestive surgery in cirrhotic patients. Gastroenterol Clin Biol. 2009;33(6–7):555–64.

    Article  CAS  PubMed  Google Scholar 

  11. Kim TH, Um SH, Yim SY, Seo YS, Yim HJ, Jeen YT, et al. The risk of perioperative adverse events in patients with chronic liver disease. Liver Int. 2015;35(3):713–23.

    Article  PubMed  Google Scholar 

  12. Neeff HP, Streule GC, Drognitz O, Tittelbach-Helmrich D, Spangenberg HC, Hopt UT, et al. Early mortality and long-term survival after abdominal surgery in patients with liver cirrhosis. Surgery. 2014;155(4):623–32.

    Article  PubMed  Google Scholar 

  13. Martin P. Perioperative considerations for patients with liver disease. Cleve Clin J Med. 2009;76(Suppl 4):S93–7.

    Article  PubMed  Google Scholar 

  14. Narr BJ, Hansen TR, Warner MA. Preoperative laboratory screening in healthy Mayo patients: cost-effective elimination of tests and unchanged outcomes. Mayo Clin Proc. 1991;66(2):155–9.

    Article  CAS  PubMed  Google Scholar 

  15. Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199(6):648–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Mansour A, Watson W, Shayani V, Pickleman J. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery. 1997;122(4):730–5. discussion 5–6

    Article  CAS  PubMed  Google Scholar 

  17. Telem DA, Schiano T, Goldstone R, Han DK, Buch KE, Chin EH, et al. Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. Clin Gastroenterol Hepatol. 2010;8(5):451–7. quiz e58

    Article  PubMed  Google Scholar 

  18. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111(4):1018–22.

    Article  CAS  PubMed  Google Scholar 

  19. Azoulay D, Buabse F, Damiano I, Smail A, Ichai P, Dannaoui M, et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg. 2001;193(1):46–51.

    Article  CAS  PubMed  Google Scholar 

  20. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology. 2002;35(5):1282–4.

    Article  PubMed  Google Scholar 

  21. Sheth M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol. 2002;2:2.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–70.

    Article  CAS  PubMed  Google Scholar 

  23. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004;40(6):897–903.

    Article  PubMed  Google Scholar 

  24. Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg. 2004;188(5):580–3.

    Article  PubMed  Google Scholar 

  25. Perkins L, Jeffries M, Patel T. Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol. 2004;2(12):1123–8.

    Article  PubMed  Google Scholar 

  26. Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg. 2005;140(7):650–4. discussion 5

    Article  PubMed  Google Scholar 

  27. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242(2):244–51.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Hanje AJ, Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007;4(5):266–76.

    Article  PubMed  Google Scholar 

  29. Suman A, Barnes DS, Zein NN, Levinthal GN, Connor JT, Carey WD. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol. 2004;2(8):719–23.

    Article  PubMed  Google Scholar 

  30. Sladen RN. Anesthetic concerns for the patient with liver disease. Anesth Analg. 2008;106(4):1–7.

    Google Scholar 

  31. Harville DD, Summerskill WH. Surgery in acute hepatitis. Causes and effects. JAMA. 1963;184:257–61.

    Article  CAS  PubMed  Google Scholar 

  32. Greenwood SM, Leffler CT, Minkowitz S. The increased mortality rate of open liver biopsy in alcoholic hepatitis. Surg Gynecol Obstet. 1972;134(4):600–4.

    CAS  PubMed  Google Scholar 

  33. Propst A, Propst T, Zangerl G, Ofner D, Judmaier G, Vogel W. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci. 1995;40(8):1805–15.

    Article  CAS  PubMed  Google Scholar 

  34. Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7(1):122–8.

    Article  CAS  PubMed  Google Scholar 

  35. Neeff H, Mariaskin D, Spangenberg HC, Hopt UT, Makowiec F. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using child and MELD scores. J Gastrointest Surg. 2011;15:1–11.

    Article  PubMed  Google Scholar 

  36. Demetriades D, Constantinou C, Salim A, Velmahos G, Rhee P, Chan L. Liver cirrhosis in patients undergoing laparotomy for trauma: effect on outcomes. J Am Coll Surg. 2004;199(4):538–42.

    Article  PubMed  Google Scholar 

  37. Nguyen GC, Correia AJ, Thuluvath PJ. The impact of cirrhosis and portal hypertension on mortality following colorectal surgery: a nationwide, population-based study. Dis Colon Rectum. 2009;52(8):1367–74.

    Article  PubMed  Google Scholar 

  38. Ghaferi AA, Mathur AK, Sonnenday CJ, Dimick JB. Adverse outcomes in patients with chronic liver disease undergoing colorectal surgery. Ann Surg. 2010;252(2):345–50.

    Article  PubMed  Google Scholar 

  39. Gelman S. General anesthesia and hepatic circulation. Can J Physiol Pharmacol. 1987;65(8):1762–79.

    Article  CAS  PubMed  Google Scholar 

  40. Sabbagh C, Fuks D, Regimbeau JM. Non-hepatic gastrointestinal surgery in patients with cirrhosis. J Visc Surg. 2014;151(3):203–11.

    Article  CAS  PubMed  Google Scholar 

  41. Cobb WS, Heniford BT, Burns JM, Carbonell AM, Matthews BD, Kercher KW. Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc. 2005;19(3):418–23.

    Article  CAS  PubMed  Google Scholar 

  42. Poggio JL, Rowland CM, Gores GJ, Nagorney DM, Donohue JH. A comparison of laparoscopic and open cholecystectomy in patients with compensated cirrhosis and symptomatic gallstone disease. Surgery. 2000;127(4):405–11.

    Article  CAS  PubMed  Google Scholar 

  43. Aranha GV, Sontag SJ, Greenlee HB. Cholecystectomy in cirrhotic patients: a formidable operation. Am J Surg. 1982;143(1):55–60.

    Article  CAS  PubMed  Google Scholar 

  44. Bloch RS, Allaben RD, Walt AJ. Cholecystectomy in patients with cirrhosis. A surgical challenge. Arch Surg. 1985;120(6):669–72.

    Article  CAS  PubMed  Google Scholar 

  45. Sleeman D, Namias N, Levi D, Ward FC, Vozenilek J, Silva R, et al. Laparoscopic cholecystectomy in cirrhotic patients. J Am Coll Surg. 1998;187(4):400–3.

    Article  CAS  PubMed  Google Scholar 

  46. Fernandes NF, Schwesinger WH, Hilsenbeck SG, Gross GW, Bay MK, Sirinek KR, et al. Laparoscopic cholecystectomy and cirrhosis: a case-control study of outcomes. Liver Transpl. 2000;6(3):340–4.

    Article  CAS  PubMed  Google Scholar 

  47. D’Albuquerque LAC, de Miranda MP, Genzini T, Copstein JL, de Oliveira e Silva A. Laparoscopic cholecystectomy in cirrhotic patients. Surg Laparosc Endosc. 1995;5(4):272–6.

    PubMed  Google Scholar 

  48. de Goede B, Klitsie PJ, Hagen SM, van Kempen BJ, Spronk S, Metselaar HJ, et al. Meta-analysis of laparoscopic versus open cholecystectomy for patients with liver cirrhosis and symptomatic cholecystolithiasis. Br J Surg. 2013;100(2):209–16.

    Article  PubMed  Google Scholar 

  49. Puggioni A, Wong LL. A metaanalysis of laparoscopic cholecystectomy in patients with cirrhosis. J Am Coll Surg. 2003;197(6):921–6.

    Article  PubMed  Google Scholar 

  50. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Harrison SA, Di Bisceglie AM. Advances in the understanding and treatment of nonalcoholic fatty liver disease. Drugs. 2003;63(22):2379–94.

    Article  CAS  PubMed  Google Scholar 

  52. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865–73.

    Article  CAS  PubMed  Google Scholar 

  53. Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45(4):600–6.

    Article  PubMed  Google Scholar 

  54. Wolter S, Dupree A, Coelius C, El Gammal A, Kluwe J, Sauer N, et al. Influence of liver disease on perioperative outcome after bariatric surgery in a northern german cohort. Obes Surg. 2017 Jan;27(1):90–95.

    Article  Google Scholar 

  55. Jan A, Narwaria M, Mahawar KK. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.

    Article  PubMed  Google Scholar 

  56. Barker KB, Palekar NA, Bowers SP, Goldberg JE, Pulcini JP, Harrison SA. Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. Am J Gastroenterol. 2006;101(2):368–73.

    Article  PubMed  Google Scholar 

  57. Furuya CK Jr, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol. 2007;22(4):510–4.

    Article  CAS  PubMed  Google Scholar 

  58. Liu X, Lazenby AJ, Clements RH, Jhala N, Abrams GA. Resolution of nonalcoholic steatohepatits after gastric bypass surgery. Obes Surg. 2007;17(4):486–92.

    Article  PubMed  Google Scholar 

  59. Hsieh WC, Chen PC, Corciova FC, Tinica G. Liver dysfunction as an important predicting risk factor in patients undergoing cardiac surgery: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(11):20712–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Hessel EA 2nd. Abdominal organ injury after cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004;8(3):243–63.

    Article  PubMed  Google Scholar 

  61. Kaplan M, Cimen S, Kut MS, Demirtas MM. Cardiac operations for patients with chronic liver disease. Heart Surg Forum. 2002;5(1):60–5.

    PubMed  Google Scholar 

  62. Klemperer JD, Ko W, Krieger KH, Connolly M, Rosengart TK, Altorki NK, et al. Cardiac operations in patients with cirrhosis. Ann Thorac Surg. 1998;65(1):85–7.

    Article  CAS  PubMed  Google Scholar 

  63. Vanhuyse F, Maureira P, Portocarrero E, Laurent N, Lekehal M, Carteaux JP, et al. Cardiac surgery in cirrhotic patients: results and evaluation of risk factors. Eur J Cardiothorac Surg. 2012;42(2):293–9.

    Article  PubMed  Google Scholar 

  64. Lopez-Delgado JC, Esteve F, Javierre C, Ventura JL, Manez R, Farrero E, et al. Influence of cirrhosis in cardiac surgery outcomes. World J Hepatol. 2015;7(5):753–60.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Filsoufi F, Salzberg SP, Rahmanian PB, Schiano TD, Elsiesy H, Squire A, et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl. 2007;13(7):990–5.

    Article  PubMed  Google Scholar 

  66. Ailawadi G, Lapar DJ, Swenson BR, Siefert SA, Lau C, Kern JA, et al. Model for end-stage liver disease predicts mortality for tricuspid valve surgery. Ann Thorac Surg. 2009;87(5):1460–7. discussion 7–8

    Article  PubMed  PubMed Central  Google Scholar 

  67. Modi A, Vohra HA, Barlow CW. Do patients with liver cirrhosis undergoing cardiac surgery have acceptable outcomes? Interact Cardiovasc Thorac Surg. 2010;11(5):630–4.

    Article  PubMed  Google Scholar 

  68. Thielmann M, Mechmet A, Neuhauser M, Wendt D, Tossios P, Canbay A, et al. Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery. Eur J Cardiothorac Surg. 2010;38(5):592–9.

    Article  PubMed  Google Scholar 

  69. Hayashida N, Shoujima T, Teshima H, Yokokura Y, Takagi K, Tomoeda H, et al. Clinical outcome after cardiac operations in patients with cirrhosis. Ann Thorac Surg. 2004;77(2):500–5.

    Article  PubMed  Google Scholar 

  70. Yamamoto T, Takazawa K, Hariya A, Ishikawa N, Dohi S, Matsushita S. Off-pump coronary artery bypass grafting in a patient with liver cirrhosis. Jpn J Thorac Cardiovasc Surg. 2002;50(12):526–9.

    Article  PubMed  Google Scholar 

  71. Tang AT, Karski J, Cusimano RJ. Successful off-pump pericardiectomy and coronary artery bypass in liver cirrhosis. J Card Surg. 2005;20(3):284–6.

    Article  PubMed  Google Scholar 

  72. Carr C, Desai J. OPCAB surgery in a cirrhotic hepatocellular carcinoma patient awaiting liver transplant. Ann Thorac Surg. 2004;78(4):1460–2.

    Article  PubMed  Google Scholar 

  73. Ben Ari A, Elinav E, Elami A, Matot I. Off-pump coronary artery bypass grafting in a patient with child class C liver cirrhosis awaiting liver transplantation. Br J Anaesth. 2006;97(4):468–72.

    Article  CAS  PubMed  Google Scholar 

  74. Gopaldas RR, Chu D, Cornwell LD, Dao TK, Lemaire SA, Coselli JS, et al. Cirrhosis as a moderator of outcomes in coronary artery bypass grafting and off-pump coronary artery bypass operations: a 12-year population-based study. Ann Thorac Surg. 2013;96(4):1310–5.

    Article  PubMed  Google Scholar 

  75. Greason KL, Mathew V, Wiesner RH, Suri RM, Rihal CS. Transcatheter aortic valve replacement in patients with cirrhosis. J Card Surg. 2013;28(5):492–5.

    Article  PubMed  Google Scholar 

  76. Thakkar B, Patel A, Mohamad B, Patel NJ, Bhatt P, Bhimani R, et al. Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis. Catheter Cardiovasc Interv. 2016;87(5):955–62.

    Article  PubMed  Google Scholar 

  77. Iwasaki A, Shirakusa T, Okabayashi K, Inutsuka K, Yoneda S, Yamamoto S, et al. Lung cancer surgery in patients with liver cirrhosis. Ann Thorac Surg. 2006;82(3):1027–32.

    Article  PubMed  Google Scholar 

  78. Weeder PD, Porte RJ, Lisman T. Hemostasis in liver disease: implications of new concepts for perioperative management. Transfus Med Rev. 2014;28(3):107–13.

    Article  PubMed  Google Scholar 

  79. Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, et al. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology. 2006;44(1):53–61.

    Article  CAS  PubMed  Google Scholar 

  80. Lorenz R, Kienast J, Otto U, Egger K, Kiehl M, Schreiter D, et al. Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol. 2003;15(1):15–20.

    Article  CAS  PubMed  Google Scholar 

  81. Bernstein DE, Jeffers L, Erhardtsen E, Reddy KR, Glazer S, Squiban P, et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology. 1997;113(6):1930–7.

    Article  CAS  PubMed  Google Scholar 

  82. Jeffers L, Chalasani N, Balart L, Pyrsopoulos N, Erhardtsen E. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology. 2002;123(1):118–26.

    Article  CAS  PubMed  Google Scholar 

  83. Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion. 2006;46(6):919–33.

    Article  CAS  PubMed  Google Scholar 

  84. Shao YF, Yang JM, Chau GY, Sirivatanauksorn Y, Zhong SX, Erhardtsen E, et al. Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Surg. 2006;191(2):245–9.

    Article  CAS  PubMed  Google Scholar 

  85. Tinmouth A. Evidence for a rationale use of frozen plasma for the treatment and prevention of bleeding. Transfus Apher Sci. 2012;46(3):293–8.

    Article  PubMed  Google Scholar 

  86. Stanworth SJ, Hyde CJ, Murphy MF. Evidence for indications of fresh frozen plasma. Transfus Clin Biol. 2007;14(6):551–6.

    Article  CAS  PubMed  Google Scholar 

  87. Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost. 2011;9(9):1713–23.

    Article  CAS  PubMed  Google Scholar 

  88. Buresi M, Hull R, Coffin CS. Venous thromboembolism in cirrhosis: a review of the literature. Can J Gastroenterol. 2012;26(12):905–8.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford). 2009;11(6):459–64.

    Article  Google Scholar 

  90. Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2014;20(25):8072–81.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Baikati K, Le DL, Jabbour II, Singhal S, Anand S. Hepatic hydrothorax. Am J Ther. 2014;21(1):43–51.

    Article  PubMed  Google Scholar 

  92. Keegan MT, Plevak DJ. Preoperative assessment of the patient with liver disease. Am J Gastroenterol. 2005;100(9):2116–27.

    Article  PubMed  Google Scholar 

  93. Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol. 1992;70(4):516–9.

    Article  CAS  PubMed  Google Scholar 

  94. Stoller JK, Lange PA, Westveer MK, Carey WD, Vogt D, Henderson JM. Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med. 1995;163(2):133–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  95. Castro M, Krowka MJ. Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med. 1996;17(1):35–48.

    Article  CAS  PubMed  Google Scholar 

  96. Krowka MJ, Cartin-Ceba R. Portopulmonary hypertension: formidable dual threat versus hopeful dual therapy. Liver Transpl. 2014;20(6):635–6.

    Article  PubMed  Google Scholar 

  97. Goldberg DS, Batra S, Sahay S, Kawut SM, Fallon MB. MELD exceptions for portopulmonary hypertension: current policy and future implementation. Am J Transplant. 2014;14(9):2081–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Kramer L, Horl WH. Hepatorenal syndrome. Semin Nephrol. 2002;22(4):290–301.

    PubMed  Google Scholar 

  99. Sagi SV, Mittal S, Kasturi KS, Sood GK. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2010;25(5):880–5.

    Article  CAS  PubMed  Google Scholar 

  100. Boyer TD, Sanyal AJ, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, et al. Impact of liver transplantation on survival of patients treated for type 1 hepatorenal syndrome (HRS-1). Liver Transpl. 2011;17:1328–32.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341(6):403–9.

    Article  CAS  PubMed  Google Scholar 

  102. Singh V, Dheerendra PC, Singh B, Nain CK, Chawla D, Sharma N, et al. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. Am J Gastroenterol. 2008;103(6):1399–405.

    Article  CAS  PubMed  Google Scholar 

  103. Cahill CJ, Pain JA, Bailey ME. Bile salts, endotoxin and renal function in obstructive jaundice. Surg Gynecol Obstet. 1987;165(6):519–22.

    CAS  PubMed  Google Scholar 

  104. Pain JA, Cahill CJ, Gilbert JM, Johnson CD, Trapnell JE, Bailey ME. Prevention of postoperative renal dysfunction in patients with obstructive jaundice: a multicentre study of bile salts and lactulose. Br J Surg. 1991;78(4):467–9.

    Article  CAS  PubMed  Google Scholar 

  105. Brimioulle S, Berre J, Dufaye P, Vincent JL, Degaute JP, Kahn RJ. Hydrochloric acid infusion for treatment of metabolic alkalosis associated with respiratory acidosis. Crit Care Med. 1989;17(3):232–6.

    Article  CAS  PubMed  Google Scholar 

  106. Mas A, Rodes J, Sunyer L, Rodrigo L, Planas R, Vargas V, et al. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. J Hepatol. 2003;38(1):51–8.

    Article  CAS  PubMed  Google Scholar 

  107. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis. 1988;8(1):12–25.

    Article  CAS  PubMed  Google Scholar 

  108. Yoon YH, Yi HY. (2006) Surveillance report #75: liver cirrhosis mortality in the United States, 1970–2003. Arlington, VA: National Institute on Alcohol Abuse and Alcoholism (Alcohol Epidemiologic Data System).

    Google Scholar 

  109. Wiklund RA. Preoperative preparation of patients with advanced liver disease. Crit Care Med. 2004;32(4 Suppl):S106–15.

    Article  PubMed  Google Scholar 

  110. Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician. 2006;74(5):756–62.

    PubMed  Google Scholar 

  111. Ansell BM, Moran H, Arden GP. Penicillamine and wound healing in rheumatoid arthritis. Proc R Soc Med. 1977;70(Suppl 3):75–7.

    PubMed  PubMed Central  Google Scholar 

  112. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology. 2003;37(6):1475–92.

    Article  PubMed  Google Scholar 

  113. Fodale V, Santamaria LB. The possible neuroprotective effect of laudanosine, an atracurium and cisatracurium metabolite. Acta Anaesthesiol Scand. 2003;47(6):780. 780−1

    Article  CAS  PubMed  Google Scholar 

  114. Mahboobi N, Esmaeili S, Safari S, Habibollahi P, Dabbagh A, Alavian SM. Halothane: how should it be used in a developing country? East Mediterr Health J. 2012;18(2):159–64.

    Article  CAS  PubMed  Google Scholar 

  115. Kenna JG. Immunoallergic drug-induced hepatitis: lessons from halothane. J Hepatol. 1997;26(Suppl 1):5–12.

    Article  CAS  PubMed  Google Scholar 

  116. Shehabi Y, Nakae H, Hammond N, Bass F, Nicholson L, Chen J. The effect of dexmedetomidine on agitation during weaning of mechanical ventilation in critically ill patients. Anaesth Intensive Care. 2010;38(1):82–90.

    CAS  PubMed  Google Scholar 

  117. Iirola T, Aantaa R, Laitio R, Kentala E, Lahtinen M, Wighton A, et al. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients. Crit Care. 2011;15(5):R257.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Wang ZX, Huang CY, Hua YP, Huang WQ, Deng LH, Liu KX. Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trial. Br J Anaesth. 2014;112(6):1055–64.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, The University of Kansas Health System, Kansas City, KS, USA

    Katherine Palmieri MD, MBA

  2. Allen Hyman Professor Emeritus of Critical Care Anesthesiology at Columbia University Medical Center, College of Physicians and Surgeons of Columbia University, New York, NY, USA

    Robert N. Sladen MBChB, MRCP(UK), FRCPC, FCCM

Authors
  1. Katherine Palmieri MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert N. Sladen MBChB, MRCP(UK), FRCPC, FCCM
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert N. Sladen MBChB, MRCP(UK), FRCPC, FCCM .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, Columbia University Medical Center, New York, New York, USA

    Gebhard Wagener

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Palmieri, K., Sladen, R.N. (2018). The Patient with Liver Disease Undergoing Non-hepatic Surgery. In: Wagener, G. (eds) Liver Anesthesiology and Critical Care Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-64298-7_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64298-7_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64297-0

  • Online ISBN: 978-3-319-64298-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation